139 related articles for article (PubMed ID: 18951925)
1. Cannabinoids and novelty investigation: influence of age and duration of exposure.
Fox KM; Sterling RC; Van Bockstaele EJ
Behav Brain Res; 2009 Jan; 196(2):248-53. PubMed ID: 18951925
[TBL] [Abstract][Full Text] [Related]
2. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
3. Repeated cannabinoid administration increases indices of noradrenergic activity in rats.
Page ME; Oropeza VC; Sparks SE; Qian Y; Menko AS; Van Bockstaele EJ
Pharmacol Biochem Behav; 2007 Jan; 86(1):162-8. PubMed ID: 17275893
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
5. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.
Drews E; Schneider M; Koch M
Pharmacol Biochem Behav; 2005 Jan; 80(1):145-50. PubMed ID: 15652390
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex.
Oropeza VC; Page ME; Van Bockstaele EJ
Brain Res; 2005 Jun; 1046(1-2):45-54. PubMed ID: 15927549
[TBL] [Abstract][Full Text] [Related]
8. Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.
Nallapaneni A; Liu J; Karanth S; Pope C
Toxicology; 2006 Oct; 227(1-2):173-83. PubMed ID: 16956707
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.
Klugmann M; Klippenstein V; Leweke FM; Spanagel R; Schneider M
Int J Neuropsychopharmacol; 2011 May; 14(4):505-17. PubMed ID: 21211107
[TBL] [Abstract][Full Text] [Related]
10. Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait.
Rodríguez-Arias M; Roger-Sánchez C; Vilanova I; Revert N; Manzanedo C; Miñarro J; Aguilar MA
Neural Plast; 2016; 2016():6481862. PubMed ID: 26881125
[TBL] [Abstract][Full Text] [Related]
11. Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.
Polissidis A; Chouliara O; Galanopoulos A; Marselos M; Papadopoulou-Daifoti Z; Antoniou K
Life Sci; 2009 Jul; 85(5-6):248-54. PubMed ID: 19508876
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
13. Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats.
Schoch H; Huerta MY; Ruiz CM; Farrell MR; Jung KM; Huang JJ; Campbell RR; Piomelli D; Mahler SV
Psychopharmacology (Berl); 2018 Jan; 235(1):121-134. PubMed ID: 29022083
[TBL] [Abstract][Full Text] [Related]
14. The synthetic cannabinoid WIN 55212-2 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animals.
Acheson SK; Moore NL; Kuhn CM; Wilson WA; Swartzwelder HS
Neurosci Lett; 2011 Jan; 487(3):411-4. PubMed ID: 21055447
[TBL] [Abstract][Full Text] [Related]
15. Novelty seeking behavior in the rat is dependent upon the integrity of the noradrenergic system.
Sara SJ; Dyon-Laurent C; Hervé A
Brain Res Cogn Brain Res; 1995 Jul; 2(3):181-7. PubMed ID: 7580400
[TBL] [Abstract][Full Text] [Related]
16. Female adolescent exposure to cannabinoids causes transgenerational effects on morphine sensitization in female offspring in the absence of in utero exposure.
Vassoler FM; Johnson NL; Byrnes EM
J Psychopharmacol; 2013 Nov; 27(11):1015-22. PubMed ID: 24048098
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons.
Muntoni AL; Pillolla G; Melis M; Perra S; Gessa GL; Pistis M
Eur J Neurosci; 2006 May; 23(9):2385-94. PubMed ID: 16706846
[TBL] [Abstract][Full Text] [Related]
18. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Wegener N; Koch M
Brain Res; 2009 Feb; 1253():81-91. PubMed ID: 19094973
[TBL] [Abstract][Full Text] [Related]
19. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
Schneider M; Drews E; Koch M
Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
[TBL] [Abstract][Full Text] [Related]
20. Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats.
Suenaga T; Ichitani Y
Behav Brain Res; 2008 Jul; 190(2):248-52. PubMed ID: 18374994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
